Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EnBio HoldingsTSE:6092 58 EV-to-EBIT is 8.76 as of Sep. 14, 2026, which is 49% below its 10-year median of 17.12. GuruFocus rates TSE:6092 with a GF Score™ of 58/100 and a GF Value™ of 円809.91 (Fairly Valued). The stock has 7 warning signs investors should review. Among 857 Business Services companies, EnBio Holdings ranks better than 59.74% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
EnBio Holdings's Enterprise Value for the quarter that ended in Mar. 2026 was 円12,889 Mil.
EnBio Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,511 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EnBio Holdings EV-to-EBIT Related Terms
EnBio Holdings EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for EnBio Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6092 vs CTAS, CPRT, GPN: EV-to-EBIT Comparison
For the Specialty Business Services subindustry, EnBio Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EnBio Holdings EV-to-EBIT vs Business Services Industry
For the Business Services industry and Industrials sector, EnBio Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where EnBio Holdings's EV-to-EBIT falls into.
EnBio Holdings's current Enterprise Value is 円13,242 Mil.
EnBio Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,511 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EnBio Holdings (TSE:6092) has a EV-to-EBIT of 8.76 as of Sep. 14, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on EnBio Holdings and its competitors. This is 49% below median its historical median of 17.12. Over the past decade, EnBio Holdings' EV-to-EBIT has ranged from 4.38 to 178.02. According to the industry distribution chart, EnBio Holdings ranks #345 out of 857 companies in the Business Services industry, placing it in the top 40.3%.
Is EnBio Holdings' EV-to-EBIT too high?
EnBio Holdings' current EV-to-EBIT of 8.76 is 49% below median its 10-year median of 17.12. Over the past 10 years, this metric has ranged from a low of 4.38 to a high of 178.02. The Business Services industry median EV-to-EBIT is 10.82. EnBio Holdings' value of 8.76 is 19% below this industry median. Based on the distribution chart, EnBio Holdings ranks #345 out of 857 companies in the Business Services industry, which is above the industry midpoint. Overall, EnBio Holdings has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' EV-to-EBIT compare to CTAS and CPRT?
According to the Business Services industry distribution chart, EnBio Holdings ranks #345 out of 857 companies for EV-to-EBIT. This puts EnBio Holdings in the upper half of its industry. The industry median EV-to-EBIT is 10.82. EnBio Holdings' value of 8.76 is 19% below this benchmark. Historically, EnBio Holdings' own EV-to-EBIT has ranged from 4.38 to 178.02 over the past decade. While the company's 10-year median is 17.12 vs. the industry median of 10.82, EnBio Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Business Services company?
The median EV-to-EBIT among Business Services companies is 10.82, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EnBio Holdings's current EV-to-EBIT of 8.76 is 19% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on EnBio Holdings and its competitors. For the Business Services industry, the median EV-to-EBIT is 10.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EnBio Holdings's current EV-to-EBIT is 8.76, which is 49% below median its own 10-year median of 17.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円809.91, compared to a current price of 円812.00 — trading 0.3% above its estimated fair value. The current EV-to-EBIT is 8.76, which is 49% below median its 10-year median of 17.12 and 19% below the Business Services industry median of 10.82. EnBio Holdings' overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current EV-to-EBIT is 8.76 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EnBio Holdings (TSE:6092) Overvalued in 2026?
Based on GuruFocus' analysis, EnBio Holdings stock appears to be overvalued.
The current stock price of 円812.00 is trading 0.3% above its estimated GF Value™ of 円809.91.
GuruFocus considers EnBio Holdings to be Fairly Valued.
Key valuation signals for TSE:6092:
EV-to-EBIT: 8.76 (49% below median its 10-year median of 17.12)
GF Value™: 円809.91 vs. price of 円812.00 (0.3% above fair value)
Industry Position: 19% below the Business Services median (#345 of 857)
No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
58GF Score
Get the complete analysis for TSE:6092
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6092 has been successfully added to your 
